Condition
Malignant Hilar Stricture
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 3 (1)
Trial Status
Recruiting1
Unknown1
Enrolling By Invitation1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06671418Phase 3Enrolling By Invitation
Primary Percutaneous Stenting Above the Ampulla Versus Endoscopic Drainage for Unresectable Malignant Hilar Biliary Obstruction
NCT06613945Not ApplicableRecruitingPrimary
ERCP With and Without EUS Guided HGS for Bilateral Biliary Decompression in Malignant Hilar Biliary Obstruction
NCT01141088Not ApplicableUnknownPrimary
Two Bilateral Metal Stenting in Hilar Malignancy
Showing all 3 trials